Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agustin Pappolla

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 30, 2026
Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosisLuca Bollo, Deborah Pareto, Paula Tagliani, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Rebound activity after fingolimod cessation: A case - control studyAndres Barboza, María Inés Gaitán, Ricardo Alonso, et al.
Neurology|February 4, 2025
Age-Related Disability Outcomes After a First Demyelinating EventAlvaro Cobo-Calvo, Pere Carbonell-Mirabent, Carmen Tur, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 2, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple SclerosisAna Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 24, 2026
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progressionAlvaro Cobo-Calvo, Juan Pablo Cuello, Enric Monreal, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 30, 2026
Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosisLuca Bollo, Deborah Pareto, Paula Tagliani, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Rebound activity after fingolimod cessation: A case - control studyAndres Barboza, María Inés Gaitán, Ricardo Alonso, et al.
Neurology|February 4, 2025
Age-Related Disability Outcomes After a First Demyelinating EventAlvaro Cobo-Calvo, Pere Carbonell-Mirabent, Carmen Tur, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 2, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple SclerosisAna Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 24, 2026
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progressionAlvaro Cobo-Calvo, Juan Pablo Cuello, Enric Monreal, et al.
Pageof 2